Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnuclease activity

N4BP2 PLSCR2 DROSHA

1.73e-04231103GO:0004518
GeneOntologyMolecularFunctionendonuclease activity

N4BP2 DROSHA

2.00e-03136102GO:0004519
GeneOntologyMolecularFunctionmRNA binding

SF1 RC3H1 YTHDC1

4.18e-03694103GO:0003729
GeneOntologyMolecularFunctiontranscription corepressor activity

SF1 TCERG1

5.55e-03229102GO:0003714
GeneOntologyMolecularFunctionhydrolase activity, acting on ester bonds

N4BP2 PLSCR2 DROSHA

6.38e-03807103GO:0016788
GeneOntologyMolecularFunctionzinc ion binding

SF1 RC3H1 PLSCR2

8.39e-03891103GO:0008270
GeneOntologyMolecularFunctionubiquitin protein ligase activity

RC3H1 SYVN1

1.41e-02372102GO:0061630
GeneOntologyBiologicalProcessmRNA splice site recognition

SF1 YTHDC1

2.77e-0452102GO:0006376
GeneOntologyBiologicalProcessmRNA metabolic process

SF1 RC3H1 TCERG1 YTHDC1

6.57e-04917104GO:0016071
GeneOntologyBiologicalProcessspliceosomal complex assembly

SF1 YTHDC1

1.00e-0399102GO:0000245
GeneOntologyBiologicalProcessregulation of mRNA metabolic process

SF1 RC3H1 YTHDC1

1.06e-03443103GO:1903311
GeneOntologyBiologicalProcessregulation of miRNA metabolic process

RC3H1 DROSHA

1.08e-03103102GO:2000628
GeneOntologyBiologicalProcessmiRNA metabolic process

RC3H1 DROSHA

1.44e-03119102GO:0010586
GeneOntologyBiologicalProcessRNA splicing

SF1 TCERG1 YTHDC1

1.51e-03502103GO:0008380
GeneOntologyBiologicalProcessribonucleoprotein complex biogenesis

SF1 YTHDC1 DROSHA

1.63e-03515103GO:0022613
GeneOntologyBiologicalProcessregulation of mRNA splicing, via spliceosome

SF1 YTHDC1

1.69e-03129102GO:0048024
GeneOntologyBiologicalProcessleukocyte activation

RC3H1 PLSCR2 SYVN1 DROSHA

1.73e-031186104GO:0045321
GeneOntologyBiologicalProcesslymphocyte differentiation

RC3H1 SYVN1 DROSHA

1.84e-03537103GO:0030098
GeneOntologyBiologicalProcessmRNA processing

SF1 TCERG1 YTHDC1

1.98e-03551103GO:0006397
GeneOntologyCellularComponentnuclear body

SF1 TCERG1 YTHDC1 PNISR ESX1

3.13e-05903105GO:0016604
GeneOntologyCellularComponentnuclear speck

TCERG1 YTHDC1 PNISR ESX1

3.39e-05431104GO:0016607
Domainzf-C3HC4

RC3H1 SYVN1

6.00e-03223102PF00097
DomainZF_RING_1

RC3H1 SYVN1

1.00e-02291102PS00518
DomainZF_RING_2

RC3H1 SYVN1

1.05e-02298102PS50089
DomainRING

RC3H1 SYVN1

1.10e-02305102SM00184
DomainZnf_RING

RC3H1 SYVN1

1.25e-02326102IPR001841
Domain-

RC3H1 SYVN1

2.28e-024491023.30.40.10
DomainZnf_RING/FYVE/PHD

RC3H1 SYVN1

2.38e-02459102IPR013083
PathwayREACTOME_MRNA_SPLICING

SF1 TCERG1

1.19e-0320142MM15411
PathwayREACTOME_MRNA_SPLICING

SF1 TCERG1

1.32e-0321242M14033
PathwayREACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA

SF1 TCERG1

2.25e-0327742MM15414
PathwayREACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA

SF1 TCERG1

2.35e-0328342M13087
PathwayREACTOME_METABOLISM_OF_RNA

SF1 TCERG1

1.06e-0261242MM15547
PathwayREACTOME_METABOLISM_OF_RNA

SF1 TCERG1

1.47e-0272442M16843
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

SF1 RC3H1 TCERG1 YTHDC1 PNISR DROSHA

2.97e-0880710622681889
Pubmed

The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1.

SF1 TCERG1

4.90e-061210211604498
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

SF1 TCERG1 YTHDC1 PNISR DROSHA

6.39e-06108210538697112
Pubmed

The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo.

SF1 TCERG1

2.22e-052510215456888
Pubmed

Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex.

SF1 TCERG1

2.22e-05251029731529
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

SF1 TCERG1 YTHDC1 DROSHA

6.52e-0584710435850772
Pubmed

The C. elegans homolog of human panic-disorder risk gene TMEM132D orchestrates neuronal morphogenesis through the WAVE-regulatory complex.

PNISR PLSCR2

1.88e-047210233726789
Pubmed

Mapping the Genetic Landscape of Human Cells.

YTHDC1 PNISR SYVN1

2.43e-0445110330033366
InteractionDCAF4 interactions

N4BP2 RC3H1 YTHDC1 SYVN1

2.34e-05378104int:DCAF4
InteractionH3C4 interactions

RC3H1 YTHDC1

3.77e-0519102int:H3C4
InteractionDAZL interactions

SF1 N4BP2 RC3H1

4.22e-05145103int:DAZL
InteractionSNRPA interactions

SF1 RC3H1 TCERG1 YTHDC1

6.05e-05482104int:SNRPA
InteractionRBM39 interactions

SF1 RC3H1 TCERG1 PNISR DROSHA

7.42e-051042105int:RBM39
InteractionSMAP2 interactions

N4BP2 RC3H1 SYVN1

9.28e-05189103int:SMAP2
InteractionPPARGC1B interactions

YTHDC1 SYVN1

1.09e-0432102int:PPARGC1B
InteractionSRSF11 interactions

TCERG1 YTHDC1 PNISR

1.15e-04203103int:SRSF11
InteractionRBM47 interactions

N4BP2 RC3H1 YTHDC1

1.16e-04204103int:RBM47
InteractionSF3B1 interactions

SF1 N4BP2 RC3H1 TCERG1

1.17e-04571104int:SF3B1
InteractionSNRNP40 interactions

RC3H1 TCERG1 YTHDC1 PNISR

1.78e-04637104int:SNRNP40
InteractionUBE2G1 interactions

RC3H1 SYVN1

1.80e-0441102int:UBE2G1
InteractionMECP2 interactions

SF1 TCERG1 YTHDC1 PNISR DROSHA

2.03e-041287105int:MECP2
InteractionDHX40 interactions

YTHDC1 PNISR DROSHA

2.10e-04249103int:DHX40
InteractionUBA2 interactions

TCERG1 YTHDC1 PNISR

2.20e-04253103int:UBA2
InteractionMTREX interactions

RC3H1 SYVN1 DROSHA

2.44e-04262103int:MTREX
InteractionSRPK2 interactions

RC3H1 YTHDC1 PNISR DROSHA

2.81e-04717104int:SRPK2
InteractionCELF1 interactions

SF1 RC3H1 TCERG1

3.22e-04288103int:CELF1
InteractionHNRNPUL2 interactions

RC3H1 YTHDC1 DROSHA

3.32e-04291103int:HNRNPUL2
InteractionSNRPA1 interactions

SF1 RC3H1 TCERG1

3.63e-04300103int:SNRPA1
InteractionSF1 interactions

SF1 RC3H1 TCERG1

3.77e-04304103int:SF1
InteractionDOT1L interactions

SF1 TCERG1 YTHDC1 DROSHA

4.42e-04807104int:DOT1L
InteractionRUNX1 interactions

SF1 TCERG1 YTHDC1

4.54e-04324103int:RUNX1
InteractionPRP4K interactions

RC3H1 TCERG1 YTHDC1

4.75e-04329103int:PRP4K
InteractionHNRNPK interactions

SF1 RC3H1 TCERG1 YTHDC1

5.45e-04853104int:HNRNPK
InteractionTMEM132D interactions

PNISR PLSCR2

5.87e-0474102int:TMEM132D
InteractionHNRNPAB interactions

N4BP2 RC3H1 DROSHA

6.75e-04371103int:HNRNPAB
InteractionHNRNPA1 interactions

SF1 RC3H1 YTHDC1 DROSHA

8.04e-04945104int:HNRNPA1
InteractionCNOT6L interactions

N4BP2 RC3H1

9.25e-0493102int:CNOT6L
InteractionMEN1 interactions

SF1 TCERG1 YTHDC1 DROSHA

1.11e-031029104int:MEN1
InteractionRNF214 interactions

N4BP2 RC3H1

1.16e-03104102int:RNF214
InteractionMSI1 interactions

RC3H1 YTHDC1

1.25e-03108102int:MSI1
InteractionRBMX interactions

SF1 RC3H1 YTHDC1

1.27e-03461103int:RBMX
InteractionWBP4 interactions

SF1 TCERG1

1.27e-03109102int:WBP4
InteractionSRPK1 interactions

RC3H1 YTHDC1 DROSHA

1.40e-03477103int:SRPK1
InteractionDDX23 interactions

TCERG1 YTHDC1 PNISR

1.42e-03480103int:DDX23
Cytoband11q13

SF1 SYVN1

2.91e-0411810211q13
CytobandEnsembl 112 genes in cytogenetic band chr11q13

SF1 SYVN1

4.17e-03454102chr11q13
GeneFamilyRing finger proteins

RC3H1 SYVN1

2.24e-032755258
CoexpressionNAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE

SF1 N4BP2 YTHDC1 PNISR

7.11e-06363104M41103
CoexpressionGSE21379_WT_VS_SAP_KO_CD4_TCELL_DN

N4BP2 RC3H1 SYVN1

4.97e-05199103M7511
CoexpressionGSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP

SF1 RC3H1 PNISR

5.05e-05200103M9449
CoexpressionMARTIN_VIRAL_GPCR_SIGNALING_DN

TCERG1 ESX1

1.72e-0452102M1330
ToppCellCOVID-19_Mild|World / Disease group, lineage and cell class

SF1 YTHDC1 PNISR

9.70e-061971035c33454b10023decd2f5ccda9229b6512659711e
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SF1 YTHDC1 PNISR

1.01e-0520010312f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

SF1 PNISR

4.69e-0414710294998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue

SF1 PNISR

4.95e-04151102999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

SF1 PNISR

5.69e-04162102b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-plasma_cell-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ESX1 SYVN1

5.97e-04166102139bf49eb3624d9eec7e8a2cb33d69716d63a7c5
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ESX1 SYVN1

5.97e-0416610285f59c3cc7db8863ec0044f1fcc14580834f830b
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESX1 SYVN1

6.12e-04168102a77259c13508f19186d7b0f80b34dc6d89497ab5
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESX1 SYVN1

6.12e-0416810241da200bbff5c663c39f67c38d6d5f43b0ad9494
ToppCellfacs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

N4BP2 DROSHA

6.33e-04171102f1fdc0ec3399ed6955976d02be7e5fc329a64276
ToppCellSevere-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

6.33e-041711027c2699f19ca38414447a286f7658f507882d57c2
ToppCell3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue

SF1 PNISR

6.33e-041711027aae88da5b37c20f10118325a048f08906be994c
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

N4BP2 TCERG1

6.48e-04173102a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

N4BP2 TCERG1

6.48e-04173102c31076c725f4cd912c56903592a2d9356ae59f54
ToppCellnormal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass

N4BP2 SYVN1

7.56e-04187102d36751372fd40a46441f07735c9c3c5dcb503f24
ToppCellMild/Remission-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

7.65e-04188102614032d18f8060bb12d1af7a1cf1cf4d8b2b505b
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

SF1 PNISR

7.73e-041891020e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

SF1 YTHDC1

7.89e-041911021ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

SF1 YTHDC1

7.97e-04192102aee6522d25e012231cdb905ce047295cb64d6e82
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

TCERG1 PNISR

7.97e-04192102916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

TCERG1 PNISR

8.05e-04193102e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SF1 PNISR

8.05e-041931024e78ddc96d8e403a21c4a303b1f26512d2ac91e8
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

PNISR SYVN1

8.22e-04195102ecaaa3d071e763c40d05d088fbf9e8ca06f78f47
ToppCell(1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)

N4BP2 PNISR

8.22e-04195102d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCellCOVID-19_Severe-B_memory|COVID-19_Severe / disease group, cell group and cell class

SF1 PNISR

8.22e-0419510254becd9e283639638fc5f13eddce224aed9391da
ToppCellnormal_Pleural_Fluid-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass

SF1 PNISR

8.30e-04196102d9951569068ad346a0764fe3bafff43e9f409992
ToppCellnormal_Pleural_Fluid|World / Location, Cell class and cell subclass

SF1 PNISR

8.30e-041961027029c9f4a826f6cfdcb5f7a472fba94e8945a771
ToppCellMegakaryocytic-erythropoietic-MEP-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

SF1 PNISR

8.30e-041961024e97010185fa9392da8f69e7b2a7395bf063f8ff
ToppCellmoderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SF1 PNISR

8.30e-041961029152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCellMild/Remission|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.30e-0419610271603a3b7df40eb3f267345f55e44a812fea7926
ToppCellSevere-B_naive-2|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.30e-041961028ed9784684de0a31e4d20a79486e9b638d5a2605
ToppCellsevere_COVID-19-B_naive|severe_COVID-19 / disease group, cell group and cell class (v2)

SF1 PNISR

8.30e-041961021a2b7c3f00098e9b4c0659b8714a0e4cf9f86f27
ToppCell10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

SF1 SYVN1

8.30e-041961026ba02b806d440eed45bad7616bf3b8be57034427
ToppCellMegakaryocytic-erythropoietic-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

SF1 PNISR

8.30e-04196102f90e7fe3a7b2fff30d01a25cc500876861c2e4f1
ToppCellMild/Remission-B_naive-2|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.39e-041971020042716ba630e4d5142cca46fcb279a2e64370f2
ToppCellControl-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.39e-04197102925bf0d38e4ce279fa45f455546ebd199282c0df
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

PNISR SYVN1

8.39e-041971027290f05d0b8465637420119941bcbf2fae44a7e4
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SF1 PNISR

8.39e-04197102bf80e39cd68fd5bb85c8726d4f82648391de74ad
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SF1 PNISR

8.39e-04197102296b27348ca7e9acf746f752cf810e4e5baea76c
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SF1 PNISR

8.39e-0419710257ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SF1 PNISR

8.39e-04197102ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3
ToppCellmLN-(2)_B_cell-(24)_B_cell_cycling|mLN / shred on region, Cell_type, and subtype

SYVN1 DROSHA

8.39e-0419710270fff2d6723f259e18e7a21d22dc46d71f0759ce
ToppCellmLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass

SYVN1 DROSHA

8.39e-04197102806dddcca85c82bd642008d930c8db16b613d88e
ToppCellCOVID-19_Severe-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Severe / Disease group, lineage and cell class

SF1 PNISR

8.39e-0419710207f74bdadfd28e1d55b3f4a3bf87d5dd65a2e9c5
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SF1 PNISR

8.39e-04197102258dfe69b5faeaee709422f873b144ca5e4a6452
ToppCell10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

PNISR SYVN1

8.39e-0419710231dfd9842410b5c629f39b5130233995dceb0aef
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SF1 PNISR

8.39e-041971029f0d91bb7aec4f2442259eca1ddf7905f8d40e9b
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

YTHDC1 PNISR

8.39e-041971020fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellSevere-B_memory-3|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.47e-04198102a3050c126799e32f742a14396236572250476820
ToppCellSevere-B_memory-0|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.47e-041981029cc75d14f1220fe15e530115f6dff09c31f07f7c
ToppCellHealthy_donor|World / disease group, cell group and cell class (v2)

SF1 PNISR

8.47e-041981021ed0b50c9754727a05c27b21f3546bf2e37eef7f
ToppCell10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SF1 PNISR

8.47e-041981025f465cf5c7493e32d9afe9e9d05757d0a95acc33
ToppCell10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SF1 PNISR

8.47e-0419810277ce3fe1ab161c0faf8987e73a64ab61294b9255
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SF1 YTHDC1

8.47e-0419810228ef3fc4c17dcb765537b75917f7db78baa522db
ToppCellmoderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SF1 PNISR

8.47e-041981020a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCellMild/Remission-B_naive-2|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.47e-04198102d238ad320e1989da01c48587f79eaeaa469cfa28
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SF1 PNISR

8.47e-0419810233a3b279c9ff3b762e52d060dae062167ca2239b
ToppCellControl-B_naive-2|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.47e-04198102b9aab1c2a0aeb5f95d24b321fe460bbab9e4e8a1
ToppCellPBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k)

SF1 PNISR

8.47e-04198102dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)

SF1 YTHDC1

8.47e-0419810244417089b62056269cac38d3134ff209c05b7007
ToppCell10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SF1 SYVN1

8.56e-04199102dd94e42b62af7cbd69c472681d3c758552694ae2
ToppCellmild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SF1 PNISR

8.56e-041991023e4baaf4ee23f257d821194468102c00a8ad2f21
ToppCell10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

SF1 SYVN1

8.56e-04199102713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

SF1 SYVN1

8.56e-04199102ea75804c34989c99aab542e6d72617ed144819b6
ToppCellmegakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class

SF1 PNISR

8.56e-0419910299a65887d3c8a2cde26693dd74404b101bba9d58
ToppCellMild/Remission-B_intermediate-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.56e-04199102592111591f0f6816fc56620cb555eb48dabf0758
ToppCellHealthy/Control|World / Disease group and Cell class

SF1 PNISR

8.56e-041991022623c42b3e79e401a485879b52e8bbcbc581544d
ToppCellMild/Remission-B_naive-9|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.56e-04199102e9af3c6a05f435ac8d7066f54feb653012b51ffb
ToppCellMild/Remission-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SF1 PNISR

8.56e-041991020451b1536be3725a520bfdd2b3dff133bea812e8
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

YTHDC1 PNISR

8.56e-04199102f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellSepsis-Bac-SEP|Sepsis / Disease, condition lineage and cell class

SF1 PNISR

8.64e-042001021f80e6a49c632b3ba0cdac1225c78e5d6d6d78a5
ToppCellmild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SF1 PNISR

8.64e-04200102c825320599a61a4c629d736f5c0fd6f1f405540a
ToppCelltumor_Lung-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass

SF1 PNISR

8.64e-0420010270d13c74548f88b1569a8d4acdf8f1fa434818e1
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_naive|COVID-19_Severe / Disease, condition lineage and cell class

SF1 PNISR

8.64e-042001021fb96090b5205e95ec21378bf4b88eec7257cf7e
ToppCellCOVID-19|World / Disease, condition lineage and cell class

SF1 YTHDC1

8.64e-042001027dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellCOVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class

SF1 PNISR

8.64e-0420010262c25042086f1afd1102e0720e933c2e476468fd

Protein segments in the cluster

PeptideGeneStartEntry
PPGPRMAPVPPWPPM

ESX1

286

Q8N693
MAPVPPWPPMAPVPP

ESX1

291

Q8N693
PWPPMAPVPPWPPMA

ESX1

296

Q8N693
WPPMAPVPTGPPMAP

ESX1

306

Q8N693
SQPPPPPPPKWPGMI

RC3H1

1006

Q5TC82
VPWMPAPPPPLNCPP

PLSCR2

71

Q9NRY7
PFPPGMFPLWPPMGP

SYVN1

376

Q86TM6
MFPLWPPMGPFPPVP

SYVN1

381

Q86TM6
FPPPWMGMPLPPPFA

SYVN1

456

Q86TM6
CFPPMPPPMPCPNNP

DROSHA

116

Q9NRR4
RPPFMPPPMSSMPPP

TCERG1

96

O14776
PPPPWQGMPPYPGME

YTHDC1

601

Q96MU7
PHPPPDQPWMPPTPG

PNISR

101

Q8TF01
NPNGPPPPWMQPPPP

SF1

416

Q15637
PPPWMQPPPPPMNQG

SF1

421

Q15637
PLLLPPPPPPPMWNP

N4BP2

351

Q86UW6
PPPPPPMWNPMIPAF

N4BP2

356

Q86UW6